Restacorin is a recently developed effective antiarrhythmic agent with primarily class Ic properties. The present paper reviews the electrophysiologic and hemodynamic effects of this compound. The major electrophysiologic effects are a depression of Vmax and an increase in AH, HV and QRS duration. The administration of restacorin does not induce significant side effects. In subjects with a normal left ventricular function, restacorin does not show negative inotropic effects. However, in patients with a decreased left ventricular function, restocorin produces a moderate negative inotropic effect.

Download full-text PDF

Source

Publication Analysis

Top Keywords

electrophysiologic hemodynamic
8
left ventricular
8
ventricular function
8
negative inotropic
8
restacorin
4
restacorin antiarrhythmic
4
antiarrhythmic drug
4
drug review
4
review electrophysiologic
4
hemodynamic properties
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!